Testing a new intervention to help young adults stop drinking alcohol
StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)
This study is testing a new online program to help young adults aged 18-24 stop drinking alcohol and see if it works better than just providing rewards for not drinking.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 104 (estimated) |
| Ages | 18 Years to 24 Years |
| Sex | All |
| Sponsor | University of Illinois at Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT05778734 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the feasibility and acceptability of a new intervention called CM-PST for young adults with Alcohol Use Disorder (AUD). The study will enroll participants aged 18-24 who meet AUD criteria and will assess their experiences with the intervention through surveys and interviews. Participants will receive the CM-PST intervention via videoconferencing over 12 weeks, with follow-up assessments at 3 and 6 months to measure efficacy. The trial includes both a single-arm pre/post study and a randomized control trial to compare CM-PST with a control group receiving only contingency management.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18-24 who currently consume alcohol at least once a week and meet the criteria for mild, moderate, or severe Alcohol Use Disorder.
Not a fit: Patients who have recently participated in substance use treatment or are currently taking medications for Alcohol Use Disorder may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve treatment outcomes for young adults struggling with alcohol use.
How similar studies have performed: Other studies have shown promise with similar interventions, but this specific approach is novel in its integration of CM-PST for young adults with AUD.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female young adults aged 18-24 yr * English-speaking * Current alcohol use greater or equal to 1 day/week via phone screening, and meet criteria for (past year) mild, moderate or severe AUD on the AUDIT and AUDADIS surveys. * Completion of written informed consent * Baseline screening study visit. Exclusion Criteria: * Participation in past 6 mo. in AUD or substance use treatment * Current use of medications used to treat AUD (e.g., naltrexone) * Lifetime DSM-5 diagnosis of schizophrenia, bipolar disorder, or any psychotic disorder. * Current use of psychoactive drugs, determined by positive drug toxicology screen * Conditions (e.g., tic disorder) that would interfere with psychophysiological indices of reward functioning * Pregnancy or intention to become pregnant * Additional exclusion criteria pertaining to fMRI scan in R00 phase only: a) bodily ferrous metals (e.g., aneurysm clips, shrapnel/retained particles) or b) claustrophobia, inability to tolerate small enclosed spaces.
Where this trial is running
Chicago, Illinois
- University of Illinois at Chicago — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Hagar Hallihan — University of Illinois at Chicago
- Study coordinator: Hagar Hallihan, PhD
- Email: hhalli2@uic.edu
- Phone: 312-413-5361
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.